— Ulf Panzer, MD
CD4+ T cells orchestrate the immune response and play a unique role in autoimmune and chronic inflammatory diseases. The characterization of distinct cytokine producing CD4+ T cell subsets has advanced our current understanding of the pathogenic mechanisms of organ-specific immunity greatly. Our group and others have shown that the recruitment of TH17 and TH1 cells as well as tissue resident memory T cells drives renal tissue damage in experimental and possibly human crescentic glomerulonephritis (GN). Despite these advances, the biological functions, regulation, and signaling pathways of the T cell- cytokine axis leading to organ injury remain to be fully understood.
To achieve this, we have the following goals: 1) nvestigation of the mechanisms and function of renal CD4+ T cell trafficking, in particular the molecular events controlling their retention or emigration from the kidney; 2) analyses of the type 1 and 3 cytokine family function, their receptors and their associated chemokines in immune-mediated renal diseases; and 3) perform a high-dimensional analysis of the CD4+ T cell immune response of crescentic GN patients using a systems immunology approach. In short, our studies will result in a better understanding of CD4+ T cell -cytokine network involvement in renal autoimmune diseases. These studies are essential to develop pathogenesis-based anti-cytokine treatment strategies.
Director of the Hamburg Center for Translational Immunology
III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE)
Martinistr. 52
20246 Hamburg, Germany
1989 - 1996
|
Study of Medicine, University of Hamburg |
1997 - 1999 | Study of Molecular Biology, ZMNH, University of Hamburg |
since 2020 - 2020
|
Director of the Hamburg Center for Translational Immunology |
since 2010
|
W3 Professor at the III. Medizinische Klinik and chief of the Division Glomerulonephritis Research / Translational Immunology, UKE |
2005 - 2010
|
Consultant, III. Medizinische Klinik, UKE |
2003 - 2004
|
DFG Postdoctoral Fellowship at the Institute for Research in Biomedicine, Bellinzona Switzerland |
1996 - 2003
|
Assistant Physician at the III. Medizinische Klinik, UKE |
1993 -1996
|
MD thesis, Medizinische Klinik, UKE |
2018 - 2020
|
Deputy Coordinator of the Else-Kröner Promotionskollegium ”iPRIME: innovative Promotionsförderung im Bereich translationale Entzündungsforschung“, UKE |
2019
|
Coordinator of the Integrated Research Training Group ”Mechanisms of Immune Mediated Tissue Injury” of the SFB 1192 |
2016
|
Coordinator DFG Collaborative Research Centre SFB 1192 “Immune-Mediated Glomerular Diseases” |
2014
|
'Franz-Volhard-Preis', German Society of Nephrology |
2009 - 2016
|
Leader DFG Clinical Research Unit KFO 228 “Immunopathogenesis and Therapy of Glomerulonephritis” |
2007
|
'Dr. Martini Preis' (award for the best research work published in 2006 at the University Hospital Hamburg-Eppendorf) |
1. | CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12. |
2. | Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients. |
3. | Pathogen-induced tissue-resident memory TH17 cells amplify autoimmune kidney disease. |
4. | Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney. |
5. | The immune system and kidney disease: basic concepts and clinical implications. |
* Represents equal contribution as co-first or co-senior authors. |
Martinistraße 52
Campus Research N27
20246 Hamburg Germany